According to filings with the U.S. Securities and Exchange Commission, ONL Therapeutics is raising up to $10,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Esposito played a…
According to filings with the U.S. Securities and Exchange Commission, ONL Therapeutics is raising $15,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Esposito played a key role…
Ann Arbor, MI – According to filings with the U.S. Securities and Exchange Commission, ONL Therapeutics is raising $2,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, David Esposito played…